Skip to content

Boston Scientific BSX Change in Inventories

Change in Inventories at other companies

Abbott logo
AbbottABT
$420M+64.7%
TFX
TeleflexTFX
-$16.47M-574%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$431M+195%
Stryker logo
StrykerSYK
$127M+36.6%
Haemonetics logo
HaemoneticsHAE
-$8.46M-2,425%
CONMED logo
CONMEDCNMD
$12.27M+64.1%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$63.44B-59.0%
P/E17.8×-44.1×
P/S3.1×-5.3×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's change in inventories?
Boston Scientific (BSX) reported change in inventories of $177M in Q1 2026.
How has Boston Scientific's change in inventories changed year-over-year?
Boston Scientific's change in inventories increased by 62.4% year-over-year, from $109M to $177M.
What is the long-term trend for Boston Scientific's change in inventories?
Over 2 years (2021 to 2023), Boston Scientific's change in inventories has grown at a 35.2% compound annual growth rate (CAGR), from $361M to $660M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.